SALL4 and acute myeloid leukemia: We noticed that SALL4 had the highest expression level in acute AML patients without treatment [69.01 (range: 17.20∼120.28)], low expression level in PR patients [4.18 (range: 1.76∼5.04)], even lower expression level in CR patients [1.82 (range: 0.50∼2.96)], and the lowest expression level in healthy controls [0.